MiRNA-200b reverses drug resistance of hepatocellular carcinoma HepG2 cells to sorafenib and its underlying mechanism
Objective To explore the effect of miRNA-200b on sorafenib resistance in hepatocellular carcinoma cells in order to increase the efficacy of the drug in advanced liver cancer patients. Methods Sorafenib resistant hepatocellular carcinoma HepG2-SR cell line was established by gradually increasing th...
Enregistré dans:
Auteurs principaux: | , , |
---|---|
Format: | article |
Langue: | ZH |
Publié: |
Editorial Office of Journal of Third Military Medical University
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/ebebf18ffa6548c1a4574feac02cd3e2 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|